{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:39:53Z","timestamp":1758267593339},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13256-016-1031-3","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T03:12:07Z","timestamp":1473131527000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Murray G.","family":"Tucker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Kekulawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"issue":"9","key":"1031_CR1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0004867412443900","volume":"46","author":"E Moore","year":"2012","unstructured":"Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis. Aust N Z J Psychiatry. 2012;46(9):864\u201378.","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"1031_CR2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/0004867414533838","volume":"48","author":"GE Sara","year":"2014","unstructured":"Sara GE, Burgess PM, Malhi GS, Whiteford HA, Hall WC. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Aust N Z J Psychiatry. 2014;48(11):1036\u201347.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1-2","key":"1031_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0920-9964(95)00108-5","volume":"20","author":"S Gupta","year":"1996","unstructured":"Gupta S, Hendricks S, Kenkel AM, Bhatia SC, Haffke EA. Relapse in schizophrenia: is there a relationship to substance abuse? Schizophr Res. 1996;20(1-2):153\u20136.","journal-title":"Schizophr Res"},{"issue":"5","key":"1031_CR4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/10550490390240792","volume":"12","author":"DH Gandhi","year":"2003","unstructured":"Gandhi DH, Bogrov MU, Osher FC, Myers CP. A comparison of the patterns of drug use among patients with and without severe mental illness. Am J Addict. 2003;12(5):424\u201331.","journal-title":"Am J Addict"},{"key":"1031_CR5","volume-title":"National Drug Strategy Household Survey detailed report: 2013","author":"AIHW","year":"2014","unstructured":"AIHW. National Drug Strategy Household Survey detailed report: 2013. Canberra: AIHW; 2014."},{"issue":"7","key":"1031_CR6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5694\/j.1326-5377.2007.tb00932.x","volume":"186","author":"SD Gray","year":"2007","unstructured":"Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust. 2007;186(7):336\u20139.","journal-title":"Med J Aust"},{"issue":"7","key":"1031_CR7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5694\/j.1326-5377.2007.tb00933.x","volume":"186","author":"L Degenhardt","year":"2007","unstructured":"Degenhardt L, Roxburgh A, McKetin R. Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia. Med J Aust. 2007;186(7):342\u20135.","journal-title":"Med J Aust"},{"issue":"5","key":"1031_CR8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0004867416641195","volume":"50","author":"C Galletly","year":"2016","unstructured":"Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50(5):410\u201372.","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"1031_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10550490802019816","volume":"17","author":"R McKetin","year":"2008","unstructured":"McKetin R, McLaren J, Lubman DI, Hides L. Hostility among methamphetamine users experiencing psychotic symptoms. Am J Addict. 2008;17(3):235\u201340.","journal-title":"Am J Addict"},{"issue":"4","key":"1031_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/09638237.2012.745184","volume":"22","author":"B Fasihpour","year":"2013","unstructured":"Fasihpour B, Molavi S, Shariat SV. Clinical features of inpatients with methamphetamine-induced psychosis. J Ment Health. 2013;22(4):341\u20139.","journal-title":"J Ment Health"},{"issue":"3","key":"1031_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.283","volume":"70","author":"R McKetin","year":"2013","unstructured":"McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry. 2013;70(3):319\u201324.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"1031_CR12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1465-3362.2010.00196.x","volume":"29","author":"P Kittirattanapaiboon","year":"2010","unstructured":"Kittirattanapaiboon P, Mahatnirunkul S, Booncharoen H, Thummawomg P, Dumrongchai U, Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev. 2010;29(4):456\u201361.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"1031_CR13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","volume":"16","author":"JR Richards","year":"1998","unstructured":"Richards JR, Derlet RW, Duncan DR. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. J Emerg Med. 1998;16(4):567\u201373.","journal-title":"J Emerg Med"},{"issue":"6","key":"1031_CR14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10398560903289975","volume":"17","author":"J Barry-Walsh","year":"2009","unstructured":"Barry-Walsh J, Daffern M, Duncan S, Ogloff J. The prediction of imminent aggression in patients with mental illness and\/or intellectual disability using the Dynamic Appraisal of Situational Aggression instrument. Australas Psychiatry. 2009;17(6):493\u20136.","journal-title":"Australas Psychiatry"},{"key":"1031_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1192\/bjp.185.3.196","volume":"185","author":"C Curran","year":"2004","unstructured":"Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry. 2004;185:196\u2013204.","journal-title":"Br J Psychiatry"},{"key":"1031_CR16","first-page":"CD003026","volume":"1","author":"SJ Shoptaw","year":"2009","unstructured":"Shoptaw SJ, Kao U, Ling W. Treatment for amphetamine psychosis. Cochrane Database Syst Rev. 2009;1:CD003026.","journal-title":"Cochrane Database Syst Rev"},{"key":"1031_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.040","volume":"150","author":"JR Richards","year":"2015","unstructured":"Richards JR, Albertson TE, Derlet RW, Lange RA, Olson KR, Horowitz BZ. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend. 2015;150:1\u201313.","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 3","key":"1031_CR18","first-page":"S43","volume":"88","author":"T Leelahanaj","year":"2005","unstructured":"Leelahanaj T, Kongsakon R, Netrakom P. A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis. J Med Assoc Thai. 2005;88 Suppl 3:S43\u201352.","journal-title":"J Med Assoc Thai"},{"issue":"16","key":"1031_CR19","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s00213-014-3485-6","volume":"231","author":"V Verachai","year":"2014","unstructured":"Verachai V, Rukngan W, Chawanakrasaesin K, Nilaban S, Suwanmajo S, Thanateerabunjong R, et al. Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine. Psychopharmacology (Berl). 2014;231(16):3099\u2013108.","journal-title":"Psychopharmacology (Berl)"},{"key":"1031_CR20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsat.2015.11.009","volume":"62","author":"G Wang","year":"2016","unstructured":"Wang G, Zhang Y, Zhang S, Chen H, Xu Z, Schottenfeld RS, et al. Aripiprazole and Risperidone for Treatment of Methamphetamine-Associated Psychosis in Chinese Patients. J Subst Abuse Treat. 2016;62:84\u20138.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"1031_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.ajp.2009.08111695","volume":"167","author":"DJ Grelotti","year":"2010","unstructured":"Grelotti DJ, Kanayama G, Pope Jr HG. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry. 2010;167(1):17\u201323.","journal-title":"Am J Psychiatry"},{"key":"1031_CR22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12888-016-0745-5","volume":"16","author":"H Zarrabi","year":"2016","unstructured":"Zarrabi H, Khalkhali M, Hamidi A, Ahmadi R, Zavarmousavi M. Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients. BMC Psychiatry. 2016;16:44.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"1031_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40291-013-0028-5","volume":"17","author":"CF Samer","year":"2013","unstructured":"Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA. Applications of CYP450 testing in the clinical setting. Mol Diagn Ther. 2013;17(3):165\u201384.","journal-title":"Mol Diagn Ther"},{"issue":"6","key":"1031_CR24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00023210-200115060-00005","volume":"15","author":"HD Desai","year":"2001","unstructured":"Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15(6):469\u201394.","journal-title":"CNS Drugs"},{"issue":"2","key":"1031_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00421012","volume":"43","author":"MM Singh","year":"1975","unstructured":"Singh MM, Kay SR. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics. Psychopharmacologia. 1975;43(2):103\u201313.","journal-title":"Psychopharmacologia"},{"issue":"1","key":"1031_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/schbul\/16.1.81","volume":"16","author":"MB Bowers Jr","year":"1990","unstructured":"Bowers Jr MB, Mazure CM, Nelson JC, Jatlow PI. Psychotogenic drug use and neuroleptic response. Schizophr Bull. 1990;16(1):81\u20135.","journal-title":"Schizophr Bull"},{"issue":"2 Suppl 1","key":"1031_CR27","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1097\/00004714-199804001-00005","volume":"18","author":"JA Lieberman","year":"1998","unstructured":"Lieberman JA, Sheitman B, Chakos M, Robinson D, Schooler N, Keith S. The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol. 1998;18(2 Suppl 1):20S\u20134S.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"1031_CR28","first-page":"109","volume":"132B","author":"AJ Bobb","year":"2005","unstructured":"Bobb AJ, Castellanos FX, Addington AM, Rapoport JL. Molecular genetic studies of ADHD: 1991 to 2004. Am J Med Genet B Neuropsychiatr Genet. 2005;132B(1):109\u201325.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"5","key":"1031_CR29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/hmg\/ddm347","volume":"17","author":"ME Talkowski","year":"2008","unstructured":"Talkowski ME, Kirov G, Bamne M, Georgieva L, Torres G, Mansour H, et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet. 2008;17(5):747\u201358.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1031_CR30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v69n0304","volume":"69","author":"S Mathias","year":"2008","unstructured":"Mathias S, Lubman DI, Hides L. Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry. 2008;69(3):358\u201367.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1031_CR31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O\u2019Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167(6):686\u201393.","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T20:01:42Z","timestamp":1601064102000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-1031-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1031"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-1031-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]},"article-number":"242"}}